The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Salicylic Acid and 17 salicylates; 15 of these ingredients were previously reviewed by the Panel, and 3 are reviewed herein for the first time. Some of the reported functions in cosmetics for ingredients in this group are hair and skin conditioning agents, and, less frequently, preservatives and fragrance ingredients. Upon review of relevant new data, including frequency and concentration of use, and consideration of data from the previous CIR report, the Panel concluded that these ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA).
LapczynskiAMcGintyDJonesLLetiziaCSApiAM. Fragrance material review on ethyl hexyl salicylate. Food Chem Toxicol. 2007;45 Suppl 1(7):S393-S396.
8.
LapczynskiAJonesLMcGintyDBhatiaSLetiziaCSApiAM. Fragrance material review on hexyl salicylate. Food Chem Toxicol. 2007;45:S410-S417.
9.
LapczynskiAJonesLMcGintyDBhatiaSPLetziaCSApiAM. Review. Fragrance material review on methyl salicylate. Food Chem Toxicol. 2007;45:S428-S452.
10.
PerkinElmer informatics. ChemDraw® 17; 2017.
11.
Advanced Chemistry Development Labs (ACD Labs). Properties estimated using ACD labs software. V11.02. 2019.
12.
Chemical Abstracts Service (CAS). Scifinder®. Substance identifier: key properties of Salicylic Acid, Hexyldodecyl Salicylic Acid, Sodium Salicylate, Tridecyl Salicylate, and Amyl Salicylate. https://www.cas.org. Last Updated 2019. Accessed January 7, 2019.
13.
FreemanAHallerHL. The preparation of amyl salicylates. J Am Chem Soc. 1938;60:2274-2275.
14.
HuaYRong-xuanMA. Synthesis of n-amyl salicylate catalyzed by sodium hydrogen sulfate. Hua Xue Yu Sheng Wu Gong Cheng. 2009;26(7):29-31.
15.
United States Pharmacopoeial Convention. The United States Pharmacopoeia (USP). 32nd ed.Rockville, Maryland: The United States Pharmacopoeial Convention; 2009.
16.
United States Pharmacopoeial Convention. The National Formulary (NF). 27th ed.Rockville, Maryland: The United States Pharmacopoeial Convention; 2009.
17.
U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary Cosmetic Registration Program - Frequency of Use of Cosmetic Ingredients. College Park, MD; 2019.
18.
Personal Care Products Council. Concentration of use by FDA product category: salicylates. Unpublished data submitted by the Personal Care Products Council on 6-11-2018; 2018. pp. 1-5.
19.
RotheHFautzRGerberE, et al.Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessment. Toxicol Lett. 2011;205(2):97-104.
20.
BremmerHJPrud'homme de LodderLCHvan EngelenJGM. Cosmetics fact sheet: to assess the risks for the consumer. Report No. RIVM 320104001/2006. Updated version for ConsExpo 4. 20200, pp. 1-77. https://www.rivm.nl/bibliotheek/rapporten/320104001.pdf. Accessed August 24, 2011.
21.
RotheH. Special aspects of cosmetic spray evaluation. Unpublished information presented to the 26 September CIR Expert Panel. Washington D.C.; 2011.
International Fragrance Association (IFRA). Sandards library. Hexyl salicylate limits in the finished product (%). https://www.ifraorg.org/en-us/standards-library. Last Updated 2007. Accessed November 30, 2018.
28.
DavisJE. Selected topics: toxicology. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med. 2007;32(1):63-69.
29.
BantiCNGiannoulisADKourkoumelisNOwczarzakAMKubickiMHadjikakouSK. Silver (I) compounds of the anti-inflammatory agents salicylic acid and p-hydroxyl-benzoic acid which modulate cell function. J Inorg Biochem. 2015;142:132-144.
ChatelainEGabardBSurberC. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol Appl Skin Physiol. 2003;16:28-35.
32.
CrossSEMegwaSABensonHAERobertsMS. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application. Pharm Res. 1999;16(3):427-433.
33.
MoodyRPAkramMDicksonEChuI. In vitro dermal absorption of methyl salicylate, ethyl parathion, and malathion: first responder safety. J Toxicol Environ Health A. 2007;70(12):985-999.
34.
RiviereJESmithCEBudsabaK, et al.Use of methyl salicylate as a stimulant to predict the percutaneous absorption of sulfur mustard. Toxicologist. 2000;54:151-152.
35.
RiviereJESmithCEBudsabaK, et al.Use of methyl salicylate as a simulant to predict the percutaneous absorption of sulfur mustard. J Appl Toxicol. 2001;21:91-99.
36.
HigoNSatoSIrieTUekamaK. Percutaneous penetration and metabolism of salicylic acid derivatives across hairless mouse skin in diffusion cell in vitro. STP Pharma Sci. 1995;5:302-308.
37.
DuncanEJSBrownALundyP, et al.Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol. 2002;22:141-148.
38.
HaydenCGRobertsMSBensonHA. Systemic absorption of sunscreen after topical application. Lancet. 1997;350:863-864.
39.
MartinDValdezJBorenJMayersohnM. Dermal absorption of camphor, menthol, and methyl salicylate in humans. J Clin Pharmacol. 2004;44:1151-1157.
40.
WatkinsonACBrainKRWaltersKAHadgraftJ. Prediction of the percutaneous penetration of ultraviolet filters used in sunscreen formulations. Int J Cosmet Sci. 1992;14:265-275.
41.
ShintakuKArimaYDanY, et al.Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta. Drug Metab Dispos. 2018;35(5):772-778.
42.
WolowichWRHadleyCMKelleyMTWalsonPDCasavantMJ. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen. J Toxicol Clin Toxicol. 2003;41(4):355-358.
European Chemicals Agency (ECHA). Registration, evaluation, and authorization of chemicals (REACH) dossier. 2-hydroxybenzoic acid 2-butyloctyl ester (Butyloctyl Salicylate). https://echa.europa.eu/registration-dossier/-/registered-dossier/25791. Last Updated 2018. Accessed October 25, 2018.
48.
National Toxicology Program (NTP). Methyl salicylate: reproduction and fertility assessment in CD-1 mice when administered by gavage. NTP-84-156; PB84-241140; 1984.
49.
FukayamaMYEasterdayODSerafinoPARenskersKJNorth-RootHSchrankelKR. Subchronic inhalation studies of complex fragrance mixtures in rats and hamsters. Toxicol Lett. 1999;111:175-187.
50.
SinghGSinhaNSinnollareddyMG. Role of apoptosis in mediating salicylic acid-induced teratogenesis in vitro. Toxicol Mech Methods. 2009;19(2):161-168.
51.
KarabulutAKUlgerHPrattenMK. Protection by free oxygen radical scavenging enzymes against salicylate-induced embryonic malformations in vitro. Toxicol In Vitro. 2000;14(14):297-307.
52.
FoulonOJausselyCRepettoMUrtizbereaMBlackerAM. Postnatal evolution of supernumerary ribs in rats after a single administration of sodium salicylate. J Appl Toxicol. 2000;20:205-209.
53.
WéryNFoulonOBlackerAPickardJJGofflotF. Vertebral malformations induced by sodium salicylate correlate with shifts in expression domains of Hox genes. Reprod Toxicol. 2005;20:39-45.
54.
ZhangQYeXWangL, et al.Embryo-fetal development toxicity of honokiol microemulsion intravenously administered to pregnant rats. Regul Toxicol Pharmacol. 2016;74:117-122.
55.
LamJPolifkaJEDohilMA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol. 2008;59:295-315.
56.
PatelVMSchwartzRAClarkLW. Safety of topical dermatologic medications in pregnancy. J Drugs Dermatol JDD. 2016;15(7):830-834.
57.
FungWOrakDReTHaugheyD. Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation. J Pharm Sci. 2008;97(3):1325-1328.
58.
MooreTJJosephMAllenBCouryLA. Enzymatically amplified voltammetric sensor for microliter sample volumes of salicylate. Anal Chem. 1995;67:1896-1902.
59.
TietzNW. Textbook of Clinical Chemistry. Philadelphia: W.B.Saunders Company; 1986.
60.
LabibRBuryDBoisleveF, et al.A kinetic-based safety assessment of consumer exposure to salicylic acid from cosmetic products demonstrates no evidence of a health risk from developmental toxicity. Regul Toxicol Pharmacol. 2018;94:245-251.
61.
International Program on Chemical Safety (IPCS). Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability. IPCS Harmonization of Approaches to the Risk Assessment from the Exposure to Chemicals. Geneva, Switzerland: World Health Organization (WHO); 2005.
62.
MadanRKLevittJ. A review of toxicity from topical salicylic acid preparations. J Am Acad Dermatol. 2014;70:788-792.
63.
European Commission. The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation- 9th revision; 2015.
64.
DavisDAKrausAThompsonGOlerichMOdioM. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin. J Pharm Sci. 1997;86(8):896-899.
65.
National Toxicology Program (NTP). NTP technical report on the photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study). NTP TR 524. NIH Publication No. 07-4472; 2007.
66.
HongHRuaDSakkiahSSelvarajCGeWTongW. Consensus modeling for prediction of estrogenic activity of ingredients commonly used in sunscreen products. Int J Environ Res Public Health. 2016;13(10):958.
67.
MillerDWhealsBBBeresfordNSumpterJP. Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. Environ Health Perspect. 2001;109(2):133-138.
68.
De JongWHArtsJHEDe KlerkA, et al.Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology. 2009;261:103-111.
MotoyoshiKToyoshimaYSatoMYoshimuraM. Comparative studies on the irritancy of oils and synthetic perfumes to the skin of rabbit, guina pig, rat, miniature swine and man. Cosmet Toiletries. 1979;94:41-48.
71.
KlecakGGeleickHFreyJR. Screening of fragrance materials for allergenicity in the guinea pig. I. Comparison of four testing methods. J Soc Cosmet Chemists Jpn. 1977;28:53-64.
72.
HowellMDManetzTSMeadeBJ. Comparison of murine assays for the identification of chemical sensitizers. Toxicol Mech Methods. 2000;10(1):1-15.
TruiteCVRPhilippsenGSUeda-NakamuraT, et al.Percutaneous penetration, melanin activation and toxicity evaluation of a phytotherapic formulation for vitiligo therapeutic. Photochem Photobiol. 2007;83:1529-1536.
75.
SharpDW. The sensitization potential of some perfume ingredients tested using a modified draize procedure. Toxicology. 1978;9:261-271.
76.
BasketterDAYorkMMcFaddenJPRobinsonMK. Determination of skin irritation potential in the human 4-h patch test. Contact Dermat. 2004;51:1-4.
77.
GreenBGShaffferGS. Psychophysical assessment of the chemical irritability of human skin. J Soc Cosmet Chemists Jpn. 1992;43:131-147.
78.
ForrerydANorinderULindbergTLindstedtM. Predicting skin sensitizers with confidence - using conformal prediction to determine applicability domain of GARD. Toxicol In Vitro. 2018;48:179-187.
79.
ClouetEKerdine-RömerSFerretPJ. Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references. Toxicol In Vitro. 2017;45:374-385.
80.
DietzLKinzebachSOhnesorgeS, et al.Proteomic allergen--peptide/protein interaction assay for the identification of human skin sensitizers. Toxicol In Vitro. 2013;27:1157-1162.
81.
AhmedSSWangNFieldingM, et al.An in vitro human skin test for assessing sensitization potential. J Appl Toxicol. 2016;36:669-684.
82.
HouFXingCLiBChengJChenWZhangM. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals. J Pharmacol Toxicol Methods. 2015;72:53-58.
83.
BasketterDAAlepeeNAshikagaT, et al.Categorization of chemicals according to their relative human skin sensitizing potency. Dermatitis. 2014;25:11-21.
84.
CroninMTDBasketterDA. Multivariate QSAR analysis of a skin sensitization database. SAR QSAR Environ Res. 1994;2(3):159-179.
85.
DimitrovSDLowLKPatlewiczGY, et al.Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates. Int J Toxicol. 2005;24:189-204.
86.
HostynekJJMageePS. Fragrance allergens: classification and ranking by QSAR. Toxicol In Vitro. 1997;11:377-384.
87.
International Fragrance Association (IFRA). Code of practice, standard on hexyl salicylate; 2007.
88.
GasparLRTharmannJMaia CamposPMBGLiebschM. Skin phototoxicity of cosmetic formulations containing photounstable and photostable UV-filters and vitamin A palmitate. Toxicol In Vitro. 2013;27:418-425.
89.
ForbesPDUrbachFDaviesRE. Phototoxicity testing of fragrance raw materials. Food Cosmet Toxicol. 1977;15:55-60.
90.
KandorovaHLetasiovaSAdriaensE, et al.EpiocularTM eye irritation test (EpiOcularTM EIT)for hazard identification and labelling of eye irritating chemicals. Toxicol In Vitro. 2017;49:21-33.
91.
CarpenterCPSmythHF. Chemical burns of the rabbit cornea. Am J Ophthalmol. 1946;29:1363-1372.
92.
FroschPJPilzb.AndersenKE, et al.Patch testing with fragrances: results of a multicenter study of the European Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes. Contact Dermat. 1995;33(5):333-342.
93.
FroschPJJohansenJDMenneT, et al.Further important sensitizers in patients sensitive to fragrances. I. Reactivity to 14 frequently used chemicals. Contact Dermat. 2002;47:78-85.
94.
LarsenWNakayamaHFischerT, et al.Fragrance contact dermatitis - a worldwide multicenter investigation (Part III). Contact Dermat. 2002;46:141-144.
ZhengYYinSXiaY, et al.Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, splkit-face, open-label, single-center study. Cutan Ocul Toxicol. 2018;3:1-21.
100.
RIFM Expert PanelBelsitoDBickersD, et al.A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients. Food Chem Toxicol. 2007;45(1S1):S318-S361.
